• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于膀胱癌中微小RNA特征鉴定新型微小RNA靶标

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

作者信息

Ichimi Takahiro, Enokida Hideki, Okuno Yasushi, Kunimoto Ryo, Chiyomaru Takeshi, Kawamoto Ken, Kawahara Kazuya, Toki Kazuki, Kawakami Kazumori, Nishiyama Kenryu, Tsujimoto Gozoh, Nakagawa Masayuki, Seki Naohiko

机构信息

Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

出版信息

Int J Cancer. 2009 Jul 15;125(2):345-52. doi: 10.1002/ijc.24390.

DOI:10.1002/ijc.24390
PMID:19378336
Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that negatively regulate protein-coding genes. To identify miRNAs that have a tumor suppressive function in bladder cancer (BC), 156 miRNAs were screened in 14 BCs, 5 normal bladder epithelium (NBE) samples and 3 BC cell lines. We identified a subset of 7 miRNAs (miR-145, miR-30a-3p, miR-133a, miR-133b, miR-195, miR-125b and miR-199a*) that were significantly downregulated in BCs. To confirm these results, 104 BCs and 31 NBEs were subjected to real-time RT-PCR-based experiments, and the expression levels of each miRNA were significantly downregulated in BCs (p < 0.0001 in all). Receiver-operating characteristic curve analysis revealed that the expression levels of these miRNAs had good sensitivity (>70%) and specificity (>75%) to distinguish BC from NBE. Our target search algorithm and gene-expression profiling in BCs (Kawakami et al., Oncol Rep 2006;16:521-31) revealed that Keratin7 (KRT7) mRNA was a common target of the downregulated miRNAs, and the mRNA expression levels of KRT7 were significantly higher in BCs than in NBEs (p = 0.0004). Spearman rank correlation analysis revealed significant inverse correlations between KRT7 mRNA expression and each downregulated miRNA (p < 0.0001 in all). Gain-of-function analysis revealed that KRT7 mRNA was significantly reduced by transfection of 3 miRNAs (miR-30-3p, miR-133a and miR-199a*) in the BC cell line (KK47). In addition, significant decreases in cell growth were observed after transfection of 3 miRNAs and si-KRT7 in KK47, suggesting that miR-30-3p, miR-133a and miR-199a* may have a tumor suppressive function through the mechanism underlying transcriptional repression of KRT7.

摘要

微小RNA(miRNA)是一类对蛋白质编码基因起负调控作用的小非编码RNA。为了鉴定在膀胱癌(BC)中具有肿瘤抑制功能的miRNA,我们在14例膀胱癌、5例正常膀胱上皮(NBE)样本和3种膀胱癌细胞系中筛选了156种miRNA。我们鉴定出了7种miRNA组成的一个子集(miR-145、miR-30a-3p、miR-133a、miR-133b、miR-195、miR-125b和miR-199a*),它们在膀胱癌中显著下调。为了证实这些结果,我们对104例膀胱癌和31例正常膀胱上皮样本进行了基于实时逆转录-聚合酶链反应(RT-PCR)的实验,并且每种miRNA的表达水平在膀胱癌中均显著下调(所有p值均<0.0001)。受试者工作特征曲线分析显示,这些miRNA的表达水平对区分膀胱癌和正常膀胱上皮具有良好的敏感性(>70%)和特异性(>75%)。我们的靶标搜索算法以及在膀胱癌中的基因表达谱分析(Kawakami等人,《肿瘤学报道》2006年;16:521 - 31)显示,角蛋白7(KRT7)mRNA是下调的miRNA的一个共同靶标,并且KRT7的mRNA表达水平在膀胱癌中显著高于正常膀胱上皮(p = 0.0004)。Spearman等级相关分析显示KRT7 mRNA表达与每种下调的miRNA之间存在显著的负相关(所有p值均<0.0001)。功能获得分析显示,在膀胱癌细胞系(KK47)中转染3种miRNA(miR-30-3p、miR-133a和miR-***)*可使KRT7 mRNA显著降低。此外,在KK47中转染3种miRNA和si-KRT7后观察到细胞生长显著下降,这表明miR-30-3p、miR-133a和miR-199a可能通过KRT7转录抑制的潜在机制发挥肿瘤抑制功能。 原文中此处miR-199a表述有误,推测应为miR-199a-3p,译文在号处按推测修改后翻译

相似文献

1
Identification of novel microRNA targets based on microRNA signatures in bladder cancer.基于膀胱癌中微小RNA特征鉴定新型微小RNA靶标
Int J Cancer. 2009 Jul 15;125(2):345-52. doi: 10.1002/ijc.24390.
2
MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.miR-133a 通过直接调控 GSTP1 诱导膀胱癌细胞系凋亡。
Urol Oncol. 2013 Jan;31(1):115-23. doi: 10.1016/j.urolonc.2010.09.017. Epub 2011 Mar 10.
3
Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.LASP1 在细胞活力中的功能作用及其在膀胱癌中受 microRNAs 的调控。
Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16.
4
miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.miR-145、miR-133a 和 miR-133b:抑癌 miRNAs 在食管鳞癌细胞中靶向 FSCN1。
Int J Cancer. 2010 Dec 15;127(12):2804-14. doi: 10.1002/ijc.25284.
5
The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.通过深度测序分析膀胱癌的微小RNA表达特征:miR-195/497簇的功能意义
PLoS One. 2014 Feb 10;9(2):e84311. doi: 10.1371/journal.pone.0084311. eCollection 2014.
6
microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.大量膀胱肿瘤中 microRNA 表达谱:鉴定与肌层浸润性膀胱癌侵袭性相关的 3 个 miRNA 特征。
Int J Cancer. 2013 Jun 1;132(11):2479-91. doi: 10.1002/ijc.27949. Epub 2013 Feb 25.
7
Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.膀胱癌中肿瘤抑制因子 microRNA-1 和 microRNA-133a 调控的新型分子靶标。
Int J Oncol. 2012 Jun;40(6):1821-30. doi: 10.3892/ijo.2012.1391. Epub 2012 Feb 29.
8
Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.双链微小RNA-199家族对整合素α3(ITGA3)的调控作为膀胱癌潜在的预后标志物
Br J Cancer. 2017 Apr 11;116(8):1077-1087. doi: 10.1038/bjc.2017.43. Epub 2017 Mar 21.
9
Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.miR-223 双链的两条互补链(miR-223-5p 和 miR-223-3p)抑制癌细胞侵袭性:靶基因参与膀胱癌的发病机制。
J Hum Genet. 2018 May;63(5):657-668. doi: 10.1038/s10038-018-0437-8. Epub 2018 Mar 14.
10
miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.miRNA 谱分析鉴定膀胱癌诊断和临床结局的候选 mirnas。
J Mol Diagn. 2013 Sep;15(5):695-705. doi: 10.1016/j.jmoldx.2013.05.008. Epub 2013 Aug 12.

引用本文的文献

1
MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma.MiR-221、miR-320a、miR133a和miR-133b作为平滑肌肉瘤潜在的生物标志物。
Front Oncol. 2025 Jun 20;15:1577859. doi: 10.3389/fonc.2025.1577859. eCollection 2025.
2
Decoding Salivary ncRNAomes as Novel Biomarkers for Oral Cancer Detection and Prognosis.解码唾液非编码RNA组作为口腔癌检测和预后的新型生物标志物
Noncoding RNA. 2025 Mar 20;11(2):28. doi: 10.3390/ncrna11020028.
3
miR-195-5p Inhibits Colon Cancer Progression via KRT23 Regulation.miR-195-5p通过调控KRT23抑制结肠癌进展。
Pharmaceutics. 2024 Dec 4;16(12):1554. doi: 10.3390/pharmaceutics16121554.
4
A bibliometric analysis of bladder cancer and microRNA research: Trends and advances from 2008 to 2022.膀胱癌与 microRNA 研究的文献计量分析:2008 年至 2022 年的趋势和进展。
Medicine (Baltimore). 2024 Oct 25;103(43):e40289. doi: 10.1097/MD.0000000000040289.
5
Relapse and Survival in Bladder Cancer Patients Undergoing microRNA-129 and microRNA-145 Assays.膀胱癌患者接受 microRNA-129 和 microRNA-145 检测后的复发和生存情况。
Asian Pac J Cancer Prev. 2024 Jun 1;25(6):2113-2121. doi: 10.31557/APJCP.2024.25.6.2113.
6
LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.长链非编码 RNA BCYRN1 作为膀胱癌血清外泌体中潜在的治疗靶点和诊断标志物。
Int J Mol Sci. 2024 May 29;25(11):5955. doi: 10.3390/ijms25115955.
7
Emerging insights into keratin 7 roles in tumor progression and metastasis of cancers.对角蛋白7在癌症肿瘤进展和转移中作用的新见解。
Front Oncol. 2024 Jan 8;13:1243871. doi: 10.3389/fonc.2023.1243871. eCollection 2023.
8
Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined model.在分子定义模型中靶向微小RNA-145介导的早期膀胱癌进展表型。
Mol Ther Nucleic Acids. 2023 Jul 3;33:960-982. doi: 10.1016/j.omtn.2023.06.009. eCollection 2023 Sep 12.
9
Tumor-Associated Fibroblast-Derived Exosomal circDennd1b Promotes Pituitary Adenoma Progression by Modulating the miR-145-5p/ONECUT2 Axis and Activating the MAPK Pathway.肿瘤相关成纤维细胞衍生的外泌体环状Dennd1b通过调节miR-145-5p/ONECUT2轴并激活丝裂原活化蛋白激酶(MAPK)途径促进垂体腺瘤进展。
Cancers (Basel). 2023 Jun 27;15(13):3375. doi: 10.3390/cancers15133375.
10
Epigenetic and Immunological Features of Bladder Cancer.膀胱癌的表观遗传和免疫学特征。
Int J Mol Sci. 2023 Jun 7;24(12):9854. doi: 10.3390/ijms24129854.